EUVIMEDEUVIMED entdecken
Crossref

Oroxylum Indicum (L.) Kurz: Neuroprotective Phytoconstituents and Advanced Anti-Parkinson Thearapeutic Potential

Meda Jhansi, Dharmasoth Rama Devi, Swathi Nageswara, Ramanamma Lalam, chandi vishala, Labhala Swathi, Kunda Daniel Raju, Bhavanam Sai Kavya

International Journal of Drug Delivery Technology · 03.06.2026 · 16 (52s)

DOI: 10.25258/ijddt.16.52s.61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 03.06.2026. Verfasst von Meda Jhansi und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The selective loss of dopaminergic neurons in the substantia nigra the hallmark of parkinson’s disease(PD),a chronic,progressive neurodegenarative condition that causes crippling motor and non motar problems. Traditional medications,especially levodopa, are therefore desperately nedded.Due to its abundance of bioactive flavonoids, particularly baicalein, chrysin,and oroxylin A, Oroxylum indicum(L) kurz, a medicinal plant belonging to the Bignoniaceae family, has become a viable option. These phytoconstituents have strong anti inflammatory, anti-apoptotic, and anti oxidant qualities that directly combat the main pathologies associated with parkison’s disease. Preclinical studies verify that O. indicum extracts significantly protect dopaminergic neurons and restore functional motor results in well-known toxin-induced models,such as MPTP and 6-hydroxydopamine (6-OHIDA). these neuroprotective effects are mediated mechanistically by reducing oxidative stress, suppressing neuroinflammatory cascades, and precisely modifying important signaling pathways, namely NF-kB inhibition and Nrf2 activation.Despite these encouraging results,poor water solubility and restricted blood-brain barrier permeability have historically hindered the clinical translation of O. indicum-derived drugs.These pharmacokinetics constraints have been successfully addressed by recent advancements in nanotechnology -based drug delivery systems,and long-term therapeutic efficacy.The neuroprotective phytoconstituents of O. indicum,their complex modes of action, and the importance of sophisticated formulation techniques in maximizing their anti-parkison potential are all critically assessed in this through analysis. In the end,O.indicum is a very promising natural medicinal platform that merits through clinical trails to determine its safety,effectiveness,and translational fessibility in the treatment of parkinson’s disease.

Zitieren

APA

Jhansi, M., Devi, D. R., Nageswara, S., Lalam, R., vishala, C., Swathi, L., Raju, K. D., & Kavya, B. S. (2026). Oroxylum Indicum (L.) Kurz: Neuroprotective Phytoconstituents and Advanced Anti-Parkinson Thearapeutic Potential. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.61

Vancouver

Jhansi M, Devi DR, Nageswara S, Lalam R, vishala C, Swathi L, et al. Oroxylum Indicum (L.) Kurz: Neuroprotective Phytoconstituents and Advanced Anti-Parkinson Thearapeutic Potential. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.61

BibTeX
@article{Jhansi2026,
  author = {Jhansi, Meda and Devi, Dharmasoth Rama and Nageswara, Swathi and Lalam, Ramanamma and vishala, chandi and Swathi, Labhala and Raju, Kunda Daniel and Kavya, Bhavanam Sai},
  title = {Oroxylum Indicum (L.) Kurz: Neuroprotective Phytoconstituents and Advanced Anti-Parkinson Thearapeutic Potential},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {52s},
  doi = {10.25258/ijddt.16.52s.61}
}
Kostenlos starten →